Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

Commission File No. 0-16614

 

NEORX CORPORATION

(Exact name of Registrant as specified in its charter)

 

Washington

 

91-1261311

(State or other jurisdiction
of incorporation or organization)

 

(IRS Employer Identification No.)

 

300 Elliott Avenue West, Suite 500, Seattle, Washington 98119-4114

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (206) 281-7001

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  ý    No  o

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act.

 

Yes  ý    No  o

 

As of November 1, 2004, 30,860,253 shares of the Registrant’s common stock, $.02 par value per share, were outstanding.

 

 



 

TABLE OF CONTENTS

 

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2004

 

PART I
FINANCIAL INFORMATION
 
 
 
 

Item 1.

Financial Statements (Unaudited):

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2004 and December 31, 2003

 

 

 

 

 

Condensed Consolidated Statements of Operations for the Three and Nine months ended September 30, 2004 and 2003

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2004 and 2003

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

PART II
OTHER INFORMATION
 
 
 
 

Item 6.

Exhibits

 

 

 

 

 

Signatures

 

 

 

 

 

Exhibit Index

 

 

2



 

PART I.  FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share data)

 

 

 

 

(unaudited)
September 30, 2004

 

December 31, 2003

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

20,599

 

$

15,166

 

Investment securities

 

1,497

 

12,335

 

Prepaid expenses and other current assets

 

436

 

652

 

Total current assets

 

22,532

 

28,153

 

 

 

 

 

 

 

Facilities and equipment

 

9,404

 

9,103

 

Less accumulated depreciation

 

2,141

 

1,632

 

Facilities and equipment, net

 

7,263

 

7,471

 

Other assets

 

67

 

67

 

Licensed products, less accumulated amortization of $83

 

1,917

 

 

 

 

 

 

 

 

Total assets

 

$

31,779

 

$

35,691

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

371

 

$

409

 

Accrued liabilities

 

1,287

 

1,295

 

Current portion of note payable

 

267

 

385

 

Total current liabilities

 

1,925

 

2,089

 

 

 

 

 

 

 

Long-term liabilities:

 

 

 

 

 

Note payable, net of current portion

 

4,004

 

4,112

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred stock, $.02 par value, 3,000,000 shares authorized:

 

 

 

 

 

Convertible preferred stock, Series 1, 205,340 shares issued and outstanding at September 30, 2004 and December 31, 2003 (entitled in liquidation to $5,300 and $5,175, respectively)

 

4

 

4

 

Convertible preferred stock, Series B, 1,575 shares issued and outstanding at September 30, 2004 and December 31, 2003 (entitled in liquidation to $15,750)

 

 

 

Common stock, $.02 par value, 60,000,000 shares authorized, 30,485,796 and 28,002,945 shares issued and outstanding at September 30, 2004 and December 31, 2003, respectively

 

610

 

560

 

Additional paid-in capital

 

254,139

 

243,365

 

Accumulated deficit, including other comprehensive loss of $3 and $7
at September 30, 2004 and December 31, 2003, respectively

 

(228,903

)

(214,439

)

Total shareholders’ equity

 

25,850

 

29,490

 

Total liabilities and shareholders’ equity

 

$

31,779

 

$

35,691

 

 

See accompanying notes to the condensed consolidated financial statements.

 

3



 

NEORX CORPORATION AND SUBSIDIARY

 

CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended September 30,

 

Nine months ended September 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

5

 

$

225

 

$

1,013

 

$

10,531

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

3,118

 

2,037

 

10,009

 

7,376

 

General and administrative

 

1,492

 

1,142

 

5,173

 

4,742

 

Total operating expenses

 

4,610

 

3,179

 

15,182

 

12,118

 

Loss from operations

 

(4,605

)

(2,954

)

(14,169

)

(1,587

)

Other income (expense):

 

 

 

 

 

 

 

 

 

Loss on sale of securities

 

 

(142

)

 

(142

)

Interest income

 

83

 

30

 

232

 

184

 

Interest expense